Get App Open
In App
News on WhatsApp
News on WhatsApp
Open App

Pfizer Ltd.

BSE: 500680 | NSE: PFIZER |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE182A01018 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Mar 23, 16:01
4551.85 -219.70 (-4.60%)
Volume
AVERAGE VOLUME
5-Day
2,059
10-Day
1,825
30-Day
4,748
636
  • Prev. Close

    4771.55

  • Open Price

    4645.05

  • Bid Price (Qty.)

    4525.00 (10)

  • Offer Price (Qty.)

    4645.00 (10)

NSE Live

Mar 23, 15:51
4560.00 -213.50 (-4.47%)
Volume
AVERAGE VOLUME
5-Day
10,786
10-Day
25,783
30-Day
53,737
14,382
  • Prev. Close

    4773.50

  • Open Price

    4770.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

Financials

Profit & Loss account of Pfizer (in Rs. Cr.) Mar 15 Mar 14 Mar 13 Mar 12 Mar 11  
  12 mths 12 mths 12 mths 12 mths 16 mths  
INCOME  
Revenue From Operations [Gross] 1,900.76 1,057.43 995.09 1,058.32 1,215.01  
Less: Excise/Sevice Tax/Other Levies 73.02 53.15 47.11 41.02 45.45  
Revenue From Operations [Net] 1,827.74 1,004.27 947.98 1,017.30 1,169.56  
Total Operating Revenues 1,853.32 1,111.81 1,050.07 1,095.44 1,252.45  
Other Income 67.35 109.38 105.24 90.56 92.90  
Total Revenue 1,920.66 1,221.19 1,155.31 1,186.00 1,345.35  
EXPENSES  
Cost Of Materials Consumed 385.84 265.77 238.49 230.77 272.65  
Purchase Of Stock-In Trade 436.38 106.27 97.23 146.81 149.99  
Operating And Direct Expenses 0.00 0.00 0.00 0.00 0.00  
Changes In Inventories Of FG,WIP And Stock-In Trade -82.36 2.84 -2.67 -18.49 -32.15  
Employee Benefit Expenses 236.36 191.77 206.70 189.63 226.99  
Finance Costs 0.77 0.36 0.24 1.91 2.47  
Depreciation And Amortisation Expenses 131.08 7.97 8.02 9.56 12.00  
Other Expenses 494.14 306.62 323.23 347.90 365.76  
Total Expenses 1,602.20 881.60 871.24 908.10 997.71  
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 318.46 339.59 284.07 277.90 347.65  
Exceptional Items -80.45 0.00 409.69 -0.38 -3.03  
Profit/Loss Before Tax 238.02 339.59 693.77 277.53 344.62  
Tax Expenses-Continued Operations  
Current Tax 151.00 113.04 195.43 94.47 126.32  
Less: MAT Credit Entitlement 0.00 0.00 0.00 0.00 0.00  
Deferred Tax -13.32 5.68 -4.86 -1.55 -8.04  
Tax For Earlier Years 0.00 0.00 0.00 0.00 0.00  
Total Tax Expenses 137.68 118.73 190.57 92.92 118.28  
Profit/Loss After Tax And Before ExtraOrdinary Items 100.34 220.86 503.20 184.61 226.34  
Profit/Loss From Continuing Operations 69.82 220.86 503.20 184.61 226.34  
Profit/Loss For The Period 69.82 220.86 503.20 184.61 226.34  
OTHER ADDITIONAL INFORMATION  
EARNINGS PER SHARE  
Basic EPS (Rs.) 21.93 74.01 168.63 56.78 68.69  
Diluted EPS (Rs.) 21.93 74.01 168.63 56.78 68.69  
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS  
Imported Raw Materials 150.29 79.91 73.83 60.08 71.01  
Indigenous Raw Materials 139.54 113.77 98.75 99.75 123.79  
STORES, SPARES AND LOOSE TOOLS  
Imported Stores And Spares 0.00 0.00 0.00 0.00 0.00  
Indigenous Stores And Spares 0.00 0.00 0.00 0.00 0.00  
DIVIDEND AND DIVIDEND PERCENTAGE  
Equity Share Dividend 57.18 1,074.29 96.99 37.30 49.24  
Tax On Dividend 11.64 182.58 16.48 6.05 7.99  
Equity Dividend Rate (%) 125.00 3,600.00 325.00 125.00 165.00  
Source : Dion Global Solutions Limited

Results of Pharmaceuticals Sector

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347